Clinical Trials

An overview of our ongoing clinical trials.

A phase II study ongoing in Sickle Cell Disease

About the study

A multi-centre, phase II, randomized, double-blind, placebo-controlled study to explore efficacy and safety of sevuparin infusion for the management of acute Vaso-Occlusive Crisis in subjects with Sickle Cell Disease is currently ongoing.

The objective of the study is to investigate the effects of sevuparin on reducing the duration and severity on the painful crisis in comparison to placebo. The results from this study will further guide the development of sevuparin in pivotal trials.

Interested in participating?

This study is currently recruiting at hospitals in The Netherlands, Turkey, Lebanon, Bahrain, Oman, Saudi Arabia and Jamaica.  If you are interested in getting involved in this clinical trial, please talk to your physician. Your physician will be able to advise you on whether you would be eligible to enroll into the trial and if participation would be right for you.

Find out more